Company News
09/02/2021
ATCC Expands Board of Directors With Three Appointments
ATCC, the world’s premier biological materials management and standards organization, announced that Dr. Melissa Rewolinski, Steve Curts and Heather Kiessling have joined its board of directors. ATCC’s board helps advise the senior leadership team on a variety of business, strategy and science-related issues. Board members work closely with management to identify new opportunities to deepen …
09/01/2021
ISOThrive Awarded Composition of Matter and Production Method Patent for its First “Farmaceutical™” to Support Animal Health
ISOThrive Inc., a microbiome therapeutics company announced that the U.S. Patent and Trademark Office has issued a Composition of Matter and Production Method patent for its first Farmaceutical™ Maltosyl-Isomaltooligosaccharides (MIMO™), a prebiotic for use as an animal feed additive and pet food supplement. USDA and University of GA studies showed MIMO as highly effective at …
08/04/2021
Allulose Patents Granted to Bonumose for Unique Enzymatic Conversion Process
Bonumose is pleased to announce that the U.S. Patent & Trademark Office has issued U.S. Patent No. 11,078,506 for “Enzymatic Production of D-Allulose”. This patent issuance follows Bonumose’s Allulose U.S. Patent No. 11,053,528 (July 6, 2021) and allulose U.S. Patent No. 10,704,069 (July 7, 2020). Bonumose has been issued additional Allulose patents and/or has patent …
08/04/2021
Embody Announces $20.5M Funding Round
Embody, Inc., a privately-held medical device company focused on soft tissue healing, announced that it has secured $11.5 million in an oversubscribed equity financing and entered into a debt financing agreement led by Horizon Technology Finance Corporation to provide up to $9 million in term loans, of which an initial $5 million has been funded, …
07/22/2021
First Two Patients Dosed in HemoShear Therapeutics Phase 2 Study
HemoShear Therapeutics, Inc., a clinical stage company developing treatments for rare metabolic disorders, dosed the first two patience in the HERO (HElp Reduce Organic Acids) Phase 2 clinical trial of HST5040, an oral small molecule drug being investigated for the treatment of patients with methylmalonic acidemia (MMA) and propionic acidemia (PA). This trial seeks to …
07/19/2021
Phlow Corp. Receives HHS Small Business Prime Contractor of the Year Award
The U.S. Department of Health and Human Services (HHS), recently awarded Phlow Corp. the Office of Small and Disadvantaged Business Utilization (OSDBU), Small Business Prime Contractor of the Year Award. Phlow Corp. is a U.S.-based, public benefit corporation committed to solving America’s broken essential medicine supply chain. This award recognizes Phlow for its performance during …
07/15/2021
VCU Health Will Anchor Redevelopment of Former Richmond Public Safety Building
As reported online by the Richmond Times Dispatch, VCU Health will anchor a new venture by Capital City Partners in downtown Richmond’s Public Safety Building at 500 N. 10th Street. The conclusion comes four months after the Richmond City Council unanimously agreed to sell the nearly 70-year-old building for $3.5 million. Capital City Partners said …
07/14/2021
Serpin Pharma Receives $1.25 M Award by The Virginia Catalyst Fund for COVID-19 Clinical Investigation
Serpin Pharma was selected to receive a $1.25 MM award from The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), for conducting a clinical investigation for the therapeutic role of SP16 drug in mitigating SARS COV2 (COVID-19) progression in hospitalized patients. The Principal Investigator is Serpin Pharma’s collaborator, Dr. Michael Yun …
07/12/2021
Governor Northam Grants $3.4 Million to Advance Research Commercialization
Governor Ralph Northam today announced that 34 small technology-focused businesses in Virginia will receive a total of $3.4 million in Commonwealth Commercialization Fund (CCF) grants to commercialize research in an array of sectors, including agricultural and environmental technologies, autonomous systems, clean energy, cybersecurity, data analytics, life sciences, and space and satellites. These awards mark the …
07/06/2021
TruGenomix Wins Southeast Life Sciences SE Color Pitch
The first SE Color Pitch event, hosted by Southeast Life Sciences, was held on June 24, 2021, featuring top minority-led, early-stage life science companies from the southeast United States. The winner of the SE Color Pitch event, TruGenomix, which will receive the $10,000 prize, sponsored by Moderna. Presenting for TruGenomix was Charles Cathlin. CEO & …
06/30/2021
ivWatch Names Kathy Cox as Chief Financial Officer
ivWatch, LLC, inventor of the first and only continuous IV infiltration detection technology, appointments Kathy Cox to Chief Financial Officer. With over 23 years of experience, including 15 years in the medical device manufacturing and healthcare markets, Cox will strengthen the ivWatch leadership team and will provide expertise in driving business growth and operational efficiencies. …
06/29/2021
Johnson & Johnson Innovation Grant Aimed at Veteran Healthcare
A 2021 report by the U.S. Department of Health and Human Services found that Veterans are significantly more likely to develop multiple chronic health conditions in their lifetime like hypertension, arthritis, and cancer compared to non-Veterans. [1] To help treat wounded warriors and keep the military community healthy, we feel we must seek to identify …
06/29/2021
Agrospheres Seeks EPA Approval For Inert Ingredient
AgroSpheres, Inc. progresses toward a key milestone in reducing pesticide impact in the environment. The submission of AgroSpheres™ Inert ingredient to the US Environmental Protection Agency (EPA) for use in agriculture inputs will further the company’s objective to make biopesticides more effective and reduce the rates of synthetic pesticide application. When approved, this technology will …
06/28/2021
CEL-SCI’s Multikine Phase 3 Study for Immunotherapy Results Released
CEL-SCI Corporation released results from its 9.5 year pivotal Phase 3 study for its immunotherapy Multikine® (Leukocyte Interleukin, Injection)* in the treatment of advanced (stages III and IV) primary (previously untreated) squamous cell carcinoma of the head and neck (SCCHN). In the intent to treat (ITT) advanced primary SCCHN patients the study showed a statistically …
06/24/2021
Children’s National Hospital joins pediatric health challenge led by Center for Advancing Innovation
Reinforcing its commitment to expanding innovation in pediatric care, Children’s National Hospital is joining with the Center for Advancing Innovation (CAI), and collaborators Resonance Philanthropies and Digital Infuzion, to launch the 2021-2022 Innovate Children’s Health Challenge to encourage the commercialization of technologies that improve children’s health care. This year’s event, Innovate Children’s Health II, focuses …
06/21/2021
Babylon Micro-Farms Gets $1M Grant from NSF
Babylon Micro-Farms has received a $1 million grant from the National Science Foundation, with the potential for $750,000 more in follow-on funding. The grant money will go towards further development of BabylonIQ, the company’s platform that remotely manages its distributed network of farms. This grant follows a 2019 Phase 1 grant of $225,000, also from …
06/16/2021
BIO-CAT Partners with Kerry for Global Distribution of OPTI-BIOME MB40 Probiotic
BIO-CAT, Inc. has formed a global partnership with Kerry, the Taste & Nutrition company and their BIO-CAT Microbials, LLC probiotic products division. Effective June 2021, Kerry will lead the sales, marketing, and distribution of BIO-CAT’s proprietary probiotic strain, OPTI-BIOME MB40®. OPTI-BIOME MB40® (Bacillus subtilis ATCC122264) is a non-GMO, highly-stable probiotic strain that the company says …
06/15/2021
CareTaker Medical and Embody Named to MedTech Innovator Top 50 Startups
MedTech Innovator, the largest accelerator of medical device companies in the world, selected 50 companies to participate in the organization’s flagship four-month Showcase and Accelerator program, featuring the industry’s most transformative device, diagnostic, and digital health technologies from around the globe. These up-and-coming startups will receive unparalleled visibility and access to leading manufacturers, providers, investors, …
06/10/2021
Understanding Barcode Verifier Discrepancies
An ISO compliant, recently recalibrated barcode verifier is arguably the best and only effective defense against barcode quality-related liability. What about barcode verifier discrepancies? There are two types of verifier discrepancies: • Inconsistency of a single verifier • Inconsistency between two or more verifiers This article focuses on the second type. A familiar scenario in …
06/09/2021
NIH Awards Vibrent Health Contract to Create a New Paradigm for Pandemic Preparedness and Response
The National Institutes of Health’s (NIH) National Cancer Institute (NCI) has awarded Vibrent Health, a digital health technology company powering the future of precision health research, the second phase of a contract to validate COVID-CARE, a digital health solution for pandemic response. The web and mobile application will enable fast and accurate screening, automated test …
06/08/2021
GPB Scientific Gets $18M Infusion
As reported online by Richmond BizSense, GPB Scientific closed on an $18 million funding round. The money will help the company roll out its Curate cell processing system, which separates and extracts cells from blood samples to create therapies for cancer and other diseases. Funding came by way of Amgen Ventures and Vensana Capital (firms …
06/08/2021
ReAlta Life Sciences Receives $3.2 Million Grant from Virginia Catalyst to Accelerate Trial for the Treatment of Acute Lung Injury Due to COVID-19
ReAlta Life Sciences has received a $3.2 million grant award from The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), to accelerate the Company’s Phase 1b clinical trial evaluating RLS-0071 for the treatment of acute lung injury (ALI) due to COVID-19. The award, which is granted to Virginia companies to support …
05/26/2021
Southern Spine Announces John E. Hart as President and Chief Executive Officer
Southern Spine, LLC, an ISO 13485:2003 certified manufacturer of implants and instruments for spinal surgery, announced that John E Hart has been named as President and Chief Executive Officer to lead the company. Hart has more than 35 years of executive leadership experience in the medical device, life science and biologics fields serving in general …
05/25/2021
CIT Announces Key Additions to GAP Funds Investment Team
The Center for Innovative Technology (CIT), the nonprofit operations arm of the Virginia Innovation Partnership Authority (VIPA), announced that CIT GAP Funds has added two new Investment Associates to its team: Dustin Dunbar and Anthony Obi Jr. As Investment Associates, Dunbar, and Obi will support CIT GAP Funds activity including deal sourcing and due diligence …